Delivery Order SPE2D021DA002-SPE2D325F220Z
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,575.60 for ENGERIX-B 20 mcg/ml syringes by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 17, 2025, will be performed at the awardee's Park Ridge location. The contract was awarded without a set-aside designation, and represents a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,181.70 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. The contract calls for the delivery of ENGERIX-B 20 MCG/ML syringes, a hepatitis B vaccine, with an ultimate completion date of August 14, 2025. This delivery order was issued without a set-aside designation, allowing DMS Pharmaceutical Group...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,969.50 on May 30, 2025, for ENGERIX-B 20 MCG/ML syringes. This firm fixed-price delivery order, which is expected to be completed by June 4, 2025, was issued without a set-aside designation. The award is funded through the Medical Supply Chain division of the Defense Logistics Agency, reflecting the Department of Defense's ongoing need for...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $7,090.20 for ENGERIX-B 20 MCG/ML vaccine syringes. The award, issued on August 6, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is funded through the Defense Logistics Agency's Medical Supply Chain program, which procures pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,969.50 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025, with an ultimate completion date of September 15, 2025. The delivery order covers ENGERIX-B 20 micrograms per milliliter in syringe format, a hepatitis B vaccine commonly administered to military personnel and federal healthcare...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $7,578.00 by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccines. The award carries no set-aside designation and has an ultimate completion date of July 30, 2025, with performance taking place at the vendor's Park Ridge, Illinois location. This delivery order...
- This delivery order for $2,362.08 was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRN, a hepatitis B vaccine, to the Defense Logistics Agency (DLA) Medical Supply Chain. The order, placed under the DLA's SPE2DB program, has a firm fixed price and an ultimate completion date of July 12, 2024. DMS Pharmaceutical Group specializes in providing a wide range...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 18, 2025, for ENGERIX-B pediatric hepatitis B vaccine (10 micrograms/0.5 milliliter syringes). This firm fixed-price delivery order carries a ceiling value of $4,243.68 and is scheduled for completion by July 21, 2025. The contract utilizes no set-aside designation, and performance will occur at the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,578.00 by the Defense Logistics Agency (DLA) on September 9, 2025, with an ultimate completion date of September 10, 2025. The contract is for the supply of ENGERIX-B PEDI 10 MCG/0.5 syringe vaccines in 0.5 milliliter quantities. This delivery order utilizes firm fixed-price pricing and was issued without a set-aside designation,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,756.00 contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, with a period of performance through May 28, 2025. DMS Pharmaceutical Group Inc. has a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F220ZDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,757.30 on July 15, 2025, for the supply of ENGERIX-B 20 MCG/ML syringes. The award, which carries an ultimate completion date of July 18, 2025, was issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain function. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion agreement that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. ENGERIX-B is a hepatitis B vaccine product, reflecting DMS Pharmaceutical Group's continued role as a critical supplier of vaccines and biologics to federal military health systems. The company's extensive contract portfolio demonstrates its established capability in delivering both branded and generic pharmaceutical products, specialty medications, and medical consumables across diverse therapeutic categories. This award reinforces DMS Pharmaceutical Group's position as a dependable provider within the federal pharmaceutical supply chain, with the ability to fulfill urgent delivery requirements to support ongoing military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/15/25 |